What's the buzz on cannabis drinks? Host Dana Taylor invites Dr. Gruber to USA TODAY’s daily news podcast, The Excerpt , to discuss some...

Tune in to the latest CannMed Coffee Talk episode with Dr. Gruber where she discusses Key findings from the MIND Program’s longitudinal...

Cannabis-infused beverages continue to grow in popularity, especially as people seek alternatives to alcohol during Dry January. In this...

Booze or weed: what’s worse for your health? While the short answer is that both can be harmful, Sumathi Reddy of The Wall Street Journal...

What do you need to know now that the US Department of Justice considering rescheduling cannabis from a Schedule I to a Schedule III drug?

On the latest episode of Chasing Life, Dr. Sanjay Gupta explores the impact of the U.S. governments proposal to reschedule cannabis to a...

Our latest publication "A survey-based, quasi-experimental study assessing a high-cannabidiol suppository for menstrual-related pain and...

Today on GBH News, Dr. Staci Gruber joins Kana Ruhalter and Arun Rath to discuss new research about changes in behavior surrounding...

Jackie Mogensen of Mother Jones interviews Dr. Gruber on how the reclassification of cannabis from Schedule I to Schedule III will impact...

This week on the Taboo to Truth podcast, Dr. Gruber joins Karen Bigman for part two of the Beyond the High - Medical Cannabis & It's...

On this @Issue on NBC10 Boston, Dr. Gruber joins hosts Sue O'Connell and Cory Smith along with guests Shaleen Title, former commissioner...

The Department of Justice has just released a statement that the Drug Enforcement Administration (DEA) will recategorize cannabis from a...

On this week's episode of Taboo to Truth, Karen Bigman invites Dr. Gruber to the podcast to discuss medical cannabis and women's health....

We are ecstatic to share that Dr. Gruber has received the Massachusetts Life Sciences Center (MLSC) Women’s Health Innovation Award....

The Coalition for Cannabis Policy, Education, and Regulation (CPEAR) hosted an ask me anything event to discuss the potential...

Results from a new study show that CBD may help alleviate short-term anxiety compared to THC. Robby Berman of Medical News Today speaks...

The conversation around legal barriers for conducting marijuana research continues in the latest Washington Post article from David...

The dialogue surrounding rescheduling cannabis from its designation as Schedule I drug as a part of the Controlled Substances Act of 1970...

Larry Luxner, senior correspondent for the American Journal of Endocannabinoid Medicine, invites Dr. Gruber to discuss her work in the...

The U.S. Department of Human Health and Services has recommended that the DEA reclassify cannabis from Schedule I to Schedule III,...